Veolia: New environmental initiatives make local plant most sustainable facility of its kind in U.S. Veolia: New ...

(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...

An experimental first-in-class oral selective partial D1/D5 dopamine receptor agonist for Parkinson's significantly reduce disease burden in two phase 3 trials.

Last year, they published the paper, “Genetic Study of Elf5 and Ehf in the Mouse Salivary Gland,” that was featured on the cover of the March 2023 issue of the Journal of Dental Research (JDR) and ...

Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often fatal, metabolic disorder X-linked adrenoleukodystrophy, or X-ALD.

To prepare for the new facility’s opening, VNA is supporting decarbonization strategies in carbon-intensive industries.

Sound Sleep LLC provides a free sleep screening and consultation to the first 50 callers, offering an oral appliance therapy ...

Demonstrating a deeply held commitment to environmental sustainability, Veolia North America today hosted a celebration at its hazardous waste treatment center in Gum Springs, Arkansas, highlighting a ...

A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...

Medical experts discuss how the Inflation Reduction Act’s out-of-pocket prescription drug cost cap, effective in 2025, may ...

While vaccines such as Uromune may not be an accessible or perfect solution for everyone, they offer real hope for people ...